Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Revenue (2016 - 2025)

Historic Revenue for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $2.4 million.

  • International Stem Cell's Revenue rose 871.96% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 1011.96%. This contributed to the annual value of $9.1 million for FY2024, which is 1663.88% up from last year.
  • As of Q3 2025, International Stem Cell's Revenue stood at $2.4 million, which was up 871.96% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Revenue peaked at $2.4 million during Q2 2025, and registered a low of $1.7 million during Q1 2021.
  • Its 5-year average for Revenue is $2.1 million, with a median of $2.0 million in 2022.
  • Per our database at Business Quant, International Stem Cell's Revenue crashed by 2974.58% in 2021 and then soared by 3185.02% in 2022.
  • International Stem Cell's Revenue (Quarter) stood at $1.8 million in 2021, then surged by 31.85% to $2.4 million in 2022, then fell by 22.26% to $1.9 million in 2023, then grew by 29.49% to $2.4 million in 2024, then dropped by 3.15% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.4 million for Q2 2025, and $2.1 million during Q1 2025.